Jiangsu Nanfang Medical (603880) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has a cash flow conversion efficiency ratio of 0.048x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥12.53 Million ≈ $1.83 Million USD) by net assets (CN¥259.57 Million ≈ $37.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Jiangsu Nanfang Medical for the company's overall valuation and market capitalisation.
Jiangsu Nanfang Medical - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Jiangsu Nanfang Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jiangsu Nanfang Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Nanfang Medical ranked by their cash flow conversion efficiency. Explore Jiangsu Nanfang Medical cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vigil Neuroscience Inc
NASDAQ:VIGL
|
-0.496x |
|
Beijing Capital International Airport Company Limited
F:BJ1
|
-0.023x |
|
Anzheng Fashion
SHG:603839
|
-0.031x |
|
Shandong Longda Meat Foodstuff Co Ltd
SHE:002726
|
-0.183x |
|
ElringKlinger AG
F:ZIL2
|
0.233x |
|
Jiangsu Apon Medical Technology Co Ltd Class A
SHE:300753
|
-0.004x |
|
Zota Health Care LImited
NSE:ZOTA
|
-0.157x |
|
Inner Mongolia North Hauler Joint Stock Co Ltd
SHG:600262
|
0.119x |
Annual Cash Flow Conversion Efficiency for Jiangsu Nanfang Medical (2012–2025)
The table below shows the annual cash flow conversion efficiency of Jiangsu Nanfang Medical from 2012 to 2025. View today's stock price for Jiangsu Nanfang Medical for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥181.17 Million ≈ $26.51 Million |
CN¥47.73 Million ≈ $6.98 Million |
0.263x | +18.34% |
| 2024-12-31 | CN¥284.41 Million ≈ $41.62 Million |
CN¥63.32 Million ≈ $9.27 Million |
0.223x | +580.74% |
| 2023-12-31 | CN¥474.22 Million ≈ $69.39 Million |
CN¥15.51 Million ≈ $2.27 Million |
0.033x | -35.01% |
| 2022-12-31 | CN¥621.48 Million ≈ $90.94 Million |
CN¥31.28 Million ≈ $4.58 Million |
0.050x | +139.12% |
| 2021-12-31 | CN¥654.90 Million ≈ $95.83 Million |
CN¥-84.25 Million ≈ $-12.33 Million |
-0.129x | -158.50% |
| 2020-12-31 | CN¥700.80 Million ≈ $102.55 Million |
CN¥154.12 Million ≈ $22.55 Million |
0.220x | +278.28% |
| 2019-12-31 | CN¥567.52 Million ≈ $83.05 Million |
CN¥32.99 Million ≈ $4.83 Million |
0.058x | -38.28% |
| 2018-12-31 | CN¥560.04 Million ≈ $81.95 Million |
CN¥52.75 Million ≈ $7.72 Million |
0.094x | +2.84% |
| 2017-12-31 | CN¥537.57 Million ≈ $78.66 Million |
CN¥49.24 Million ≈ $7.20 Million |
0.092x | -76.34% |
| 2016-12-31 | CN¥256.69 Million ≈ $37.56 Million |
CN¥99.35 Million ≈ $14.54 Million |
0.387x | -5.01% |
| 2015-12-31 | CN¥222.51 Million ≈ $32.56 Million |
CN¥90.66 Million ≈ $13.27 Million |
0.407x | +16.89% |
| 2014-12-31 | CN¥210.90 Million ≈ $30.86 Million |
CN¥73.52 Million ≈ $10.76 Million |
0.349x | +191.73% |
| 2013-12-31 | CN¥168.57 Million ≈ $24.67 Million |
CN¥20.14 Million ≈ $2.95 Million |
0.119x | -80.93% |
| 2012-12-31 | CN¥121.38 Million ≈ $17.76 Million |
CN¥76.07 Million ≈ $11.13 Million |
0.627x | -- |
About Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of transdermal products, medical adhesive tapes and bandages, sports protective equipment, first aid kits, nitrile gloves, and protective equipment in China and internationally. The company offers medical proof fabrics, care products, band-aids, and applications; medical w… Read more